EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal
15/09/2023 19:11
BRUSSELS, Sept 15 (Reuters) - Pfizer's PFE.N $43
billion bid for Seagen SGEN.O will be decided by EU antitrust
regulators by Oct. 19, a regulatory filing showed on Friday.
U.S. pharmaceutical company Pfizer announced the deal, its
biggest, in March for Washington-based Seagen, a pioneer of
antibody-drug conjugates, which work like "guided missiles"
designed to destroy cancer while sparing healthy cells.
The European Commission can either clear the deal after a
preliminary review or it can start a four-month long
investigation if it has serious concerns.
Pfizer sought EU antitrust approval on Thursday.
(Reporting by Foo Yun Chee; editing by Grant McCool)
((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters
Messaging: foo.yunchee.thomsonreuters.com@reuters.net))